T

$TYRA

2 articles found
2 positive
0 negative
0 neutral
The Motley FoolThe Motley Fool··Jonathan Ponciano

Boone Capital Exits 372% Biotech Winner to Chase Emerging Clinical Plays

Boone Capital liquidates entire $13.57M Cogent Biosciences stake despite 372% gain, reallocating to earlier-stage biotech plays like TYRA. Strategic rebalancing in volatile sector.
MDTTYRAIONSCOGTBMRN+2biotechclinical-stage
The Motley FoolThe Motley Fool··Jonathan Ponciano

Major Fund Liquidates $69M Viridian Position Despite 75% Annual Rally

Commodore Capital liquidates its entire $69M Viridian position despite the stock's 75% annual rally, signaling strategic reallocation ahead of anticipated FDA decisions.
VRDNALKSTYRAbiotech portfolio exitposition liquidation